Kayitalire Louis
- SEC CIK
- 0001831519
No open-market purchases or sales filed in the past year.
Current role at each company
- FSTX F-star Therapeutics, Inc.CHIEF MEDICAL OFFICERas of Mar 9, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Kayitalire Louis as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 4, 2021 (view filing) | Nov 2 | 2 days | Kayitalire LouisChief Medical Officer | SSale | −64 | $6.83 | −$436.84 | −0.1%54.3K after | 2 lots |
| Oct 6, 2021 (view filing) | Oct 4 | 2 days | Kayitalire LouisChief Medical Officer | SSale | −64 | $7.23 | −$462.72 | −0.1%54.3K after | |
| Jul 7, 2021 (view filing) | Jul 2 | 5 days | Kayitalire LouisChief Medical Officer | SSale | −1.05K | $8.43 | −$8.89K | −1.9%54.4K after |